Exelixis
EXEL
#1793
Rank
NZ$20.13 B
Marketcap
NZ$75.09
Share price
-0.12%
Change (1 day)
21.96%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company